The Dividend Yield as of September 2024 (TTM) for AlloVir, Inc. (ALVR) is 0%

According to AlloVir, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

AlloVir, Inc. (ALVR) Historical Dividend Yield (quarterly & annually)

How has ALVR Dividend Yield performed in the past?

The mean historical Dividend Yield of AlloVir, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ALVR's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.

AlloVir, Inc. (ALVR) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of AlloVir, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AlloVir, Inc. (ALVR) Average Dividend Yield

How has ALVR Dividend Yield performed in the past?

The current Dividend Yield of AlloVir, Inc. (ALVR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AlloVir, Inc. (ALVR) Dividend Yield vs. Peers

How is ALVR’s Dividend Yield compared to its peers?

AlloVir, Inc.’s Dividend Yield is less than Anebulo Pharmaceuticals, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than AN2 Therapeutics, Inc. (0%), less than Aerovate Therapeutics, Inc. (0%), less than Adagene Inc. (0%), less than Homology Medicines, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Atreca, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than 4D Molecular Therapeutics, Inc. (0%), less than Acrivon Therapeutics, Inc. Common Stock (0%), less than Cullinan Oncology, Inc. (0%), less than Agios Pharmaceuticals, Inc. (0%), less than Crinetics Pharmaceuticals, Inc. (0%), less than Inhibrx, Inc. (4.80%), less than Merus N.V. (0%), less than Lyell Immunopharma, Inc. (0%), less than Kronos Bio, Inc. (0%), less than AnaptysBio, Inc. (0%),

Build a custom stock screener for AlloVir, Inc. (ALVR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AlloVir, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AlloVir, Inc. (ALVR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AlloVir, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.